Reproductive immunology: the field, read carefully

Reproductive immunology is the study of how the maternal immune system interacts with implantation and pregnancy. It is a real field with real findings – some immune dysregulation does cause recurrent failure or loss in a small minority of patients. It is also a field where the gap between hypothesis and evidence is unusually wide, and where some clinics offer treatments well before the data justifies them.

The legitimate clinical questions

Pregnancy is, immunologically, an unusual situation: the mother carries a half-foreign genetic entity for nine months without rejecting it. The mechanisms that allow this involve T-regulatory cells, NK cell modulation, complement regulation, and a controlled cytokine environment. When any of these go wrong, implantation may fail or pregnancy may be lost. That much is established.

Conditions with established immune contribution

Antiphospholipid syndrome (APS) – clearly causal in recurrent loss, treated with heparin and aspirin. Untreated thyroid autoimmunity – associated with recurrent loss, treated with thyroid hormone optimisation. Some chronic endometritis – treated with antibiotics, with documented improvement in subsequent transfer outcomes. These three sit on solid evidential ground.

Conditions and treatments with weaker evidence

Elevated NK cells (peripheral or uterine), Th1/Th2 ratio imbalance, HLA matching between partners. These are biologically plausible hypotheses with some published association studies but limited high-quality interventional evidence. Treatments offered for them – intralipid, IVIg, prednisone, lymphocyte immunotherapy – have varying levels of support, mostly not strong.

How to read a recommendation

If you are being offered an immune workup, ask: which specific tests, what would each result change in our plan, and what is the evidence that the proposed treatment improves live-birth rates in patients like me. If the answer is vague or marketing-tinged, treat it as data about the clinic, not about the medicine.

When immune workup is reasonable

After three or more good-quality embryo transfers without pregnancy. After two or more pregnancy losses, particularly second-trimester or with documented chromosomally-normal embryos. As part of an overall evaluation when no other cause has been found. Not as a routine first-cycle add-on.

Questions worth asking your doctor

• What specifically are we testing for, and what would each result actually change in our plan?
• Which proposed treatments have rigorous evidence, and which are exploratory?
• What would you do in my situation, knowing what we know?
• What is the cost of the workup and any planned therapy?

This essay is educational. Every patient’s situation is different – the right plan is shaped in conversation with a fertility specialist who knows the full picture.